Скачать или смотреть AAO 2025: Retinal Toxicity of Antipsychotic Medications - What Retina Specialists Need to Know

Dr. Sharon Fekrat discusses the retinal manifestations of antipsychotic medications at the American Academy of Ophthalmology (AAO) 2025 meeting. Learn about the risks associated with first-generation antipsychotics like thioridazine, the rare side effects of second-generation drugs, and the importance of considering systemic medications when evaluating retinal findings. Essential insights for retina specialists and ophthalmologists.
Key Topics Covered:
Retinal toxicity of thioridazine and its long-term effects
Differences between first-generation (typical) and second-generation (atypical) antipsychotics
Rare cases of cystoid macular edema with second-generation antipsychotics
The role of psilocybin and its lack of retinal toxicity
Clinical implications for retina specialists
Keywords: AAO 2025, retinal toxicity, antipsychotic medications, thioridazine, risperidone, cystoid macular edema, psilocybin, retina specialist, ophthalmology, medication-induced retinal changes